Josephine Chen

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer

R. Ferris, Q. Le, L. Mell, 2021, Cancers.